Abstract
Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer.
Keywords
Pancreatic cancerMedicinePancreatic ductal adenocarcinomaCancerAdenocarcinomaPancreasOncologyInternal medicineGeneral surgery
Affiliated Institutions
Related Publications
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Abstract Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the aver...
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients’ advanced disease...
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
Pancreatic ductal adenocarcinoma is the fourth cause of death in the Western world. Surgery remains the only treatment offering an advantage in terms of overall survival (5-year...
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Abstract Pancreatic ductal adenocarcinoma (PDAC) is poorly responsive to therapies and histologically contains a paucity of neoplastic cells embedded within a dense desmoplastic...
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma
Abstract BACKGROUND A prospective, randomized Phase III trial was performed to determine whether, compared with gemcitabine (GEM) alone, the addition of cisplatin (CDDP) to GEM ...
Publication Info
- Year
- 2010
- Type
- review
- Volume
- 362
- Issue
- 17
- Pages
- 1605-1617
- Citations
- 2522
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2522
OpenAlex
Cite This
Manuel Hidalgo
(2010).
Pancreatic Cancer.
New England Journal of Medicine
, 362
(17)
, 1605-1617.
https://doi.org/10.1056/nejmra0901557
Identifiers
- DOI
- 10.1056/nejmra0901557